Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KHG21834

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
New compounds were screened to develop effective drugs against glutamate-induced toxicity. The present study assessed the effects… Expand
2015
2015
Abstract We have previously shown that 2-(3-(benzo[d]thiazol-2-yl)ureido)acetate (KHG21834) attenuates amyloid beta(Aβ)25–35… Expand
Highly Cited
2011
Highly Cited
2011
Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE inhibitor, free-radical scavenger… Expand
2010
2010
Beta-Amyloid (ABeta)-induced neuroinflammation is one of the key events in the development of neurodegenerative disease. We… Expand
2010
2010
We previously reported that KHG21834, a benzothiazole derivative, attenuates the beta-amyloid (Aβ)-induced degeneration of both… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
2007
2007
We have investigated the effect of KHG21834, a benzothiazole derivative, on the amyloid beta protein (Abeta)-induced cell death… Expand